TY - JOUR
T1 - Photoacoustic diagnosis of pharmacokinetics and vascular shutdown effects in photodynamic treatment with indocyanine green-lactosome for a subcutaneous tumor in mice
AU - Tsunoi, Yasuyuki
AU - Araki, Koji
AU - Ozeki, Eiichi
AU - Hara, Isao
AU - Shiotani, Akihiro
AU - Terakawa, Mitsuhiro
AU - Sato, Shunichi
N1 - Funding Information:
This paper was partially prepared on the basis of data from chapter 3 in the PhD thesis of Y. Tsunoi [ 35 ]. The authors acknowledge Dr. Yoshihiro Miyagawa, Mr. Ryota Watanabe, Mr. Yusuke Akutsu and Ms. Tsuyako Ohkura for their technical assistance in the experiments. We also thank Advantest Corporation for the use of the optical parametric oscillator and the single element ultrasound sensor and the Department of Plastic and Reconstructive Surgery of National Defense Medical College for the use of the ICG FL imaging system. This work was partially supported by a grant from the Tateishi Science and Technology Foundation.
Publisher Copyright:
© 2019
PY - 2019/6
Y1 - 2019/6
N2 - Indocyanine green lactosome (ICG-lactosome) is an attractive new-generation agent for photodynamic therapy (PDT) that is characterized by a near-infrared excitation wavelength and high stability in the bloodstream. Fluorescence imaging has been used to examine its pharmacokinetics in vivo, but no depth-resolved information can be obtained with this method. In this study, we applied photoacoustic (PA) imaging to visualize the depth distribution of ICG-lactosome in a mouse subcutaneous tumor model. With this method, the depth distribution of blood vessels can also be visualized, enabling detection of vascular shutdown effects due to PDT. We performed PA imaging of both the distributions of ICG-lactosome and blood vessels in a tumor before and after PDT, and we found that PA signals originating from ICG-lactosome were greatly increased at 18 h after drug injection but rapidly decreased after PDT. These results indicate efficient accumulation of ICG-lactosome and rapid photobleaching due to the PDT reaction in the tumor, respectively. After PDT, PA amplitudes of hemoglobin were significantly decreased, being attributable to vascular shutdown effects. These results show the usefulness of PA imaging for monitoring not only photosensitizer accumulation and bleaching but also vascular responses in PDT with ICG-lactosome. This method can be applied to the diagnosis of many types of PDT processes.
AB - Indocyanine green lactosome (ICG-lactosome) is an attractive new-generation agent for photodynamic therapy (PDT) that is characterized by a near-infrared excitation wavelength and high stability in the bloodstream. Fluorescence imaging has been used to examine its pharmacokinetics in vivo, but no depth-resolved information can be obtained with this method. In this study, we applied photoacoustic (PA) imaging to visualize the depth distribution of ICG-lactosome in a mouse subcutaneous tumor model. With this method, the depth distribution of blood vessels can also be visualized, enabling detection of vascular shutdown effects due to PDT. We performed PA imaging of both the distributions of ICG-lactosome and blood vessels in a tumor before and after PDT, and we found that PA signals originating from ICG-lactosome were greatly increased at 18 h after drug injection but rapidly decreased after PDT. These results indicate efficient accumulation of ICG-lactosome and rapid photobleaching due to the PDT reaction in the tumor, respectively. After PDT, PA amplitudes of hemoglobin were significantly decreased, being attributable to vascular shutdown effects. These results show the usefulness of PA imaging for monitoring not only photosensitizer accumulation and bleaching but also vascular responses in PDT with ICG-lactosome. This method can be applied to the diagnosis of many types of PDT processes.
KW - Biodegradable nanomicelles
KW - Indocyanine green-lactosome
KW - Photoacoustic imaging
KW - Photodynamic therapy
KW - Photosensitizer dosimetry
KW - Vascular shutdown
UR - http://www.scopus.com/inward/record.url?scp=85065783233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065783233&partnerID=8YFLogxK
U2 - 10.1016/j.pdpdt.2019.04.031
DO - 10.1016/j.pdpdt.2019.04.031
M3 - Article
C2 - 31054334
AN - SCOPUS:85065783233
SN - 1572-1000
VL - 26
SP - 436
EP - 441
JO - Photodiagnosis and Photodynamic Therapy
JF - Photodiagnosis and Photodynamic Therapy
ER -